(SMAX) Hamilton U.S. Equity YIELD - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Etf • ISIN: CA4079161051

Dividend, Yield, Equity, Market

Description: SMAX Hamilton U.S. Equity YIELD

The Hamilton U.S. Equity YIELD MAXIMIZER ETF (SMAX) is a Canadian ETF that provides investors with exposure to the U.S. equity market, focusing on maximizing yields. As a US Equity ETF, it is likely to hold a diversified portfolio of U.S. stocks, potentially tilted towards dividend-paying constituents to achieve its yield maximization objective.

Given its Morningstar US Market TR CAD index, SMAX likely tracks the overall U.S. market performance, adjusted for the Canadian dollar. The ETF is managed by Hamilton Capital, a firm with expertise in income-focused investment products, as evident from their website (http://www.hamilton-capital.com).

Analyzing the ETFs recent price action, we observe a bullish trend, as the last price of $18.88 is above both its 20-day ($18.46) and 50-day ($17.97) simple moving averages. However, it is below its 200-day SMA ($18.53), indicating a potential resistance level. The Average True Range (ATR) of $0.18 (0.93%) suggests relatively low volatility, which may be attractive to income-focused investors seeking stable returns.

With Assets Under Management (AUM) of $667.30M CAD, SMAX has achieved a respectable size, potentially benefiting from economies of scale and liquidity. As a U.S. equity ETF, its performance is likely to be influenced by the overall U.S. stock market, interest rates, and currency fluctuations between the USD and CAD.

Forecasting SMAXs future performance, we can anticipate that its yield maximization strategy will continue to be influenced by the U.S. dividend landscape and overall equity market conditions. Given the current technical trends and fundamental data, a potential short-term target could be the 52-week high of $20.07, while support may be found around the 52-week low of $16.28. If the U.S. market continues to trend upwards and dividend yields remain attractive, SMAX may benefit, potentially leading to a price appreciation towards $19.50 in the near term, assuming the current bullish trend persists and AUM continues to grow.

Additional Sources for SMAX ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

SMAX ETF Overview

Market Cap in USD 599m
Category US Equity
IPO / Inception 2023-10-25

SMAX ETF Ratings

Growth Rating 44.9
Fundamental -
Dividend Rating 82.6
Rel. Strength -3.91
Analysts -
Fair Price Momentum 16.91 CAD
Fair Price DCF -

SMAX Dividends

Dividend Yield 12m 15.16%
Yield on Cost 5y 21.51%
Annual Growth 5y 152.18%
Payout Consistency 66.7%
Payout Ratio %

SMAX Growth Ratios

Growth Correlation 3m 94.5%
Growth Correlation 12m 30.9%
Growth Correlation 5y 86%
CAGR 5y 23.76%
CAGR/Max DD 5y 1.26
Sharpe Ratio 12m 0.74
Alpha -2.47
Beta 0.884
Volatility 9.71%
Current Volume 15.3k
Average Volume 20d 18.4k
Stop Loss 18.6 (-2.8%)
What is the price of SMAX shares?
As of July 26, 2025, the stock is trading at CAD 19.14 with a total of 15,330 shares traded.
Over the past week, the price has changed by -0.26%, over one month by +2.38%, over three months by +12.20% and over the past year by +14.04%.
Is Hamilton U.S. Equity YIELD a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, Hamilton U.S. Equity YIELD (TO:SMAX) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 44.92 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SMAX is around 16.91 CAD . This means that SMAX is currently overvalued and has a potential downside of -11.65%.
Is SMAX a buy, sell or hold?
Hamilton U.S. Equity YIELD has no consensus analysts rating.
What are the forecasts for SMAX share price target?
According to our own proprietary Forecast Model, SMAX Hamilton U.S. Equity YIELD will be worth about 20.3 in July 2026. The stock is currently trading at 19.14. This means that the stock has a potential upside of +5.85%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 20.3 5.9%